甲氨蝶呤治疗罕见副作用:药物性骨病伴下肢多发骨折
本文报告一例类风湿关节炎患者在接受甲氨蝶呤治疗期间,左足(跟骨前突、跟骨结节)及右小腿和足部(跟骨前部与背侧、骰骨及胫骨远端)出现多发疼痛性功能不全骨折,均被误诊为骨质疏松性骨折。骨折发生于开始甲氨蝶呤治疗后8个月至35个月之间。停用甲氨蝶呤后疼痛迅速缓解,未再发生骨折。
要点
- 甲氨蝶呤相关骨病罕见,典型累及下肢,影像学形态有特征性,但常被误诊为骨质疏松性功能不全骨折。
- 正确且早期诊断是治疗和预防进一步骨病变的关键。
- 本例骨折发生于开始甲氨蝶呤治疗后8个月至35个月之间,停用甲氨蝶呤后疼痛迅速缓解且未再发生骨折。
核心结论
- 本病例有力说明提高对甲氨蝶呤骨病认识的重要性,以便采取适当治疗措施,包括停用甲氨蝶呤。
研究设计与样本
- 本文为病例报告,报告一例接受甲氨蝶呤治疗的类风湿关节炎患者出现下肢多发功能不全骨折。
主要发现
- 患者左足(跟骨前突、跟骨结节)及右小腿和足部(跟骨前部与背侧、骰骨及胫骨远端)出现多发疼痛性功能不全骨折。
- 骨折发生于开始甲氨蝶呤治疗后8个月至35个月之间,均被误诊为骨质疏松性骨折。
- 停用甲氨蝶呤后疼痛迅速缓解,未再发生骨折。
临床怎么用
- 作者认为提高对甲氨蝶呤骨病的认识很重要,以便采取适当治疗措施,包括停用甲氨蝶呤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Methotrexate is associated with bone lesions that are rare and, although presenting with a typical localisation to the lower extremities and appearing with a characteristic radiologic morphology, largely unknown and often misdiagnosed as osteoporotic insufficiency fractures. The correct and early diagnosis, however, is key for treatment and prevention of further osteopathology. Here, we present a patient with rheumatoid arthritis who developed multiple painful insufficiency fractures in the left foot (processus anterior calcanei, tuber calcanei) and in the right lower leg and foot (anterior and dorsal calcaneus and at the cuboid and distal tibia) during therapy with methotrexate, which were all misdiagnosed as osteoporotic. The fractures occurred between 8 months and 35 months after starting methotrexate. Discontinuation of methotrexate resulted in rapid pain relief and no further fractures have occurred. This case powerfully demonstrates the importance of raising awareness of methotrexate osteopathy in order to take appropriate therapeutic measures, including and perniciously discontinuing methotrexate.
引用
- Singh D, Hesse N, Skapenko A, et al. A rare side effect of methotrexate therapy: drug-induced osteopathy with multiple fractures of the lower limb. RMD Open. 2023. PMID: 36810186. doi:10.1136/rmdopen-2023-002982
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。